Diabetes

Victoza effort featuring Southern cuisine queen Deen draws flak

January 17, 2012

Novo Nordisk is courting controversy with a Victoza-branded type 2 diabetes education campaign featuring Southern-fried celebrity chef Paula Deen and her sons.
 

Merck signs sports talker Golic for low blood sugar awareness effort

September 21, 2011

Defensive tackle-turned-sports radio talker Mike Golic has signed on to Merck and the American College of Endocrinology's Blood Sugar Basics program, which emphasizes the import of blood sugar control for people with type 2 diabetes.
 

Results of heart study bring Bydureon back from brink, analyst says

July 08, 2011

The results, showing the long-acting diabetes med had passed a crucial test of its effects on heart rhythms, put the drug back on track after a spate of regulatory delays, wrote one analyst.
 

For Tradjenta, a tough climb, and for Lilly, a vital one

May 05, 2011

Lilly/Boehringer Ingelheim's third-to-market DPP-4 inhibitor Tradjenta, approved earlier this week for the treatment of type 2 diabetes, faces an uphill battle for market share against Merck's entrenched market leader Januvia and BMS/AstraZeneca's Onglyza.
 

Apps on fire, but pharmas losing the mobile health arms race, says report

February 16, 2011

Pharma investment in app development exploded last year, as companies branched out beyond diabetes, but industry spending on mobile is still dwarfed by other healthcare players, according to an Ernst & Young report.
 

Sanofi-Aventis builds out diabetes social media presence

February 16, 2011

Sanofi-Aventis US is expanding its social media footprint with a new "Discuss Diabetes" blog and a "WhyInsulin" YouTube channel.
 

Company news: Takeda and Teva

December 28, 2010

Takeda granted generics firm Teva a license to market authorized copies in the US, starting Aug. 17, 2012, for best-selling diabetes pill Actos, and on Dec. 14, 2012, for Actoplus met (Actos plus metformin).
 

Ad-ucation? Sorvinos plug Lantus in Sanofi web effort

September 21, 2010

Sanofi Aventis launched a Lantus-branded "diabetes awareness campaign" featuring Paul and Mira Sorvino.
 

Exclusive: Takeda launches Actos DTC campaign today

July 15, 2010

Takeda is kicking off a direct-to-consumer campaign for type 2 diabetes pill Actos today, as the FDA considers whether Actos' direct rival, the GlaxoSmithKline drug Avandia, can remain on the market.
 

Insulin pen makers roll out new promos

May 05, 2010

Sanofi-Aventis US is rolling out a consumer campaign for its Lantus SoloStar pen aimed at getting people with type 2 diabetes to think differently about insulin, while Novo Nordisk revs up another racing-themed social media effort for its FlexPen.
 

Bayer glucose meter aimed at gamers

April 27, 2010

Bayer Diabetes Care partnered with Nintendo on a glucose meter for kids that incorporates gaming.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!
 
Popular Topics
Adherence Advertising Approval Brand Corporate Reputation DDMAC Digital Direct To Consumer (DTC) DTC Facebook FDA Generic Guidance Launch Loyalty Program Magazine Major Statement Manufacturing Media Medical Education Off-label Online OPDP Social Media Television